GlassScriptPhysician profile
Melissa Bustos
NPI 1275902181
$3,868.96
in general payments reported to CMS, 2019-2025
16 companies · $715 in 2025
The $715 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $244 · 2022: $1,389 · 2023: $1,023 · 2024: $498 · 2025: $715.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,137 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,136.56 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,121.22 | 2022-2025 | |
| Genzyme Corporation | $881.30 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $699.00 | 2021-2023 | Dupixent |
| Janssen Biotech, INC. | $323.59 | 2022-2024 | Tremfya |
| Amgen INC. | $245.12 | 2022-2024 | Otezla |
| Novartis Pharmaceuticals Corporation | $141.05 | 2022-2023 | |
| Leo Pharma INC. | $99.91 | 2022-2025 | Adbry |
| Pfizer INC. | $94.10 | 2021-2022 | |
| Ucb, INC. | $70.19 | 2022-2024 | Bimzelx |
| Paratek Pharmaceuticals, INC. | $40.96 | 2023 | Nuzyra |
| Dermira, INC. | $36.66 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $32.42 | 2024 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $25.27 | 2025 | |
| Arcutis Biotherapeutics, INC. | $24.59 | 2025 | Zoryve |
| Lilly USA, LLC | $18.42 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $15.16 | 2024 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Bustos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.